Fig. 2: Immuno-oncology biomarkers in EOEGC, IOEGC, and AOEGC.
From: Multi-omic characterization of early-onset esophagogastric cancer
A Bar graph for TMB-High status (≥10 mutations/MB). B Bar graph for dMMR/MSI-H status. C Bar graph for PD-L1 positive status as determined by immunohistochemistry from the 22c3 assay. *p < 0.05; **p < 0.01; *** p < 0.001 when compared to EOEGC by chi-square or Fisher’s exact tests.
